Top Key Companies for Bacteriophages (Phage) Products Market: Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage.
Global Bacteriophages (Phage) Products Market Size was estimated at USD 7002.1 million in 2022 and is projected to reach USD 8072.87 million by 2028, exhibiting a CAGR of 2.4% during the forecast period.
Global Bacteriophages (Phage) Products Market Overview And Scope:
The Global Bacteriophages (Phage) Products Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Bacteriophages (Phage) Products utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bacteriophages (Phage) Products market.
Global Bacteriophages (Phage) Products Market Segmentation
By Type, Bacteriophages (Phage) Products market has been segmented into:
DsDNA Type
SsDNA Type
SsRNA Type
Others
By Application, Bacteriophages (Phage) Products market has been segmented into:
Animal Health
Aquaculture
Agriculture
Food Industry
Others
Regional Analysis of Bacteriophages (Phage) Products Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Bacteriophages (Phage) Products Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Bacteriophages (Phage) Products market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Bacteriophages (Phage) Products market.
Top Key Companies Covered in Bacteriophages (Phage) Products market are:
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences
Inc
Pharmex Group
LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International
Inc.
MicroMir
iNtODEWORLD
Inc.
NEXTBIOTICS
Armata Pharmaceuticals
Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Bacteriophages (Phage) Products Market by Type
5.1 Bacteriophages (Phage) Products Market Overview Snapshot and Growth Engine
5.2 Bacteriophages (Phage) Products Market Overview
5.3 DsDNA Type
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 DsDNA Type: Geographic Segmentation
5.4 SsDNA Type
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 SsDNA Type: Geographic Segmentation
5.5 SsRNA Type
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 SsRNA Type: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Bacteriophages (Phage) Products Market by Application
6.1 Bacteriophages (Phage) Products Market Overview Snapshot and Growth Engine
6.2 Bacteriophages (Phage) Products Market Overview
6.3 Animal Health
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Animal Health: Geographic Segmentation
6.4 Aquaculture
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Aquaculture: Geographic Segmentation
6.5 Agriculture
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Agriculture: Geographic Segmentation
6.6 Food Industry
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Food Industry: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2030F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Bacteriophages (Phage) Products Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Bacteriophages (Phage) Products Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Bacteriophages (Phage) Products Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PROTEON PHARMACEUTICALS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PHAGELUX
7.4 INTRALYTIX
7.5 MICREOS
7.6 ELIAVA BIOPREPARATIONS
7.7 LOCUS BIOSCIENCES
7.8 INC
7.9 PHARMEX GROUP
7.10 LLC
7.11 PHERECYDES PHARMA
7.12 APS BIOCONTROL LTD. (APS)
7.13 QINGDAO PHAGEPHARM BIO-TECH
7.14 FIXED-PHAGE LIMITED
7.15 ZEPTOMETRIX
7.16 PHAGE INTERNATIONAL
7.17 INC.
7.18 MICROMIR
7.19 INTODEWORLD
7.20 INC.
7.21 NEXTBIOTICS
7.22 ARMATA PHARMACEUTICALS
7.23 INC.
7.24 INNOPHAGE
7.25 ADAPTIVE PHAGE THERAPEUTICS
7.26 TECHNOPHAGE
Chapter 8: Global Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 DsDNA Type
8.2.2 SsDNA Type
8.2.3 SsRNA Type
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Animal Health
8.3.2 Aquaculture
8.3.3 Agriculture
8.3.4 Food Industry
8.3.5 Others
Chapter 9: North America Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 DsDNA Type
9.4.2 SsDNA Type
9.4.3 SsRNA Type
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Animal Health
9.5.2 Aquaculture
9.5.3 Agriculture
9.5.4 Food Industry
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 DsDNA Type
10.4.2 SsDNA Type
10.4.3 SsRNA Type
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Animal Health
10.5.2 Aquaculture
10.5.3 Agriculture
10.5.4 Food Industry
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 DsDNA Type
11.4.2 SsDNA Type
11.4.3 SsRNA Type
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Animal Health
11.5.2 Aquaculture
11.5.3 Agriculture
11.5.4 Food Industry
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 DsDNA Type
12.4.2 SsDNA Type
12.4.3 SsRNA Type
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Animal Health
12.5.2 Aquaculture
12.5.3 Agriculture
12.5.4 Food Industry
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 DsDNA Type
13.4.2 SsDNA Type
13.4.3 SsRNA Type
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Animal Health
13.5.2 Aquaculture
13.5.3 Agriculture
13.5.4 Food Industry
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Bacteriophages (Phage) Products Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 DsDNA Type
14.4.2 SsDNA Type
14.4.3 SsRNA Type
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Animal Health
14.5.2 Aquaculture
14.5.3 Agriculture
14.5.4 Food Industry
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Bacteriophages (Phage) Products Scope:
|
Report Data
|
Bacteriophages (Phage) Products Market
|
|
Bacteriophages (Phage) Products Market Size in 2022
|
USD 7002.10 million
|
|
Bacteriophages (Phage) Products CAGR 2023 - 2030
|
2.40%
|
|
Bacteriophages (Phage) Products Base Year
|
2022
|
|
Bacteriophages (Phage) Products Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage.
|
|
Key Segments
|
By Type
DsDNA Type
SsDNA Type
SsRNA Type
Others
By Applications
Animal Health
Aquaculture
Agriculture
Food Industry
Others
|
